Laura M. Hack

Psychiatry

401 Quarry Rd
Palo Alto, CA 94304

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.

Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 08, 2026

Conserved brain-wide emergence of emotional response from sensory experience in humans and mice.

Conserved brain-wide emergence of emotional response from sensory experience in humans and mice.

Journal: Science (New York, N.Y.)

Published: May 29, 2025

Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA: A Randomized Clinical Trial.

Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA: A Randomized Clinical Trial.

Journal: JAMA network open

Published: April 30, 2025

A Stratified Precision Medicine Trial Targeting Selective Mechanisms of Alpha 2A Agonism as a Treatment for the Cognitive Biotype of Depression: The BIomarker Guided (BIG) Study for Depression.

A Stratified Precision Medicine Trial Targeting Selective Mechanisms of Alpha 2A Agonism as a Treatment for the Cognitive Biotype of Depression: The BIomarker Guided (BIG) Study for Depression.

Journal: Research square

Published: March 10, 2025

A cognitive neural circuit biotype of depression showing functional and behavioral improvement after transcranial magnetic stimulation in the B-SMART-fMRI trial.

A cognitive neural circuit biotype of depression showing functional and behavioral improvement after transcranial magnetic stimulation in the B-SMART-fMRI trial.

Journal: Nature. Mental health

Published: February 06, 2025

A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression.

A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression.

Journal: Nature. Mental health

Published: January 04, 2025

Opioids Diminish the Placebo Antidepressant Response: A Post Hoc Analysis of a Randomized Controlled Ketamine Trial.

Opioids Diminish the Placebo Antidepressant Response: A Post Hoc Analysis of a Randomized Controlled Ketamine Trial.

Journal: medRxiv : the preprint server for health sciences

Published: October 14, 2024

Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.

Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.

Journal: Brain, behavior, and immunity

Published: August 18, 2024

Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trial.

Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trial.

Journal: Journal of affective disorders

Published: July 19, 2024

Reduction in Trauma-Related Symptoms After Anesthetic-Induced Intra-Operative Dreaming.

Reduction in Trauma-Related Symptoms After Anesthetic-Induced Intra-Operative Dreaming.

Journal: The American journal of psychiatry

Published: March 13, 2024

Randomized trial of ketamine masked by surgical anesthesia in patients with depression.

Randomized trial of ketamine masked by surgical anesthesia in patients with depression.

Journal: Nature. Mental health

Published: January 08, 2024

Prevalence and characteristics of preoperative patients with depression.

Prevalence and characteristics of preoperative patients with depression.

Journal: British journal of anaesthesia

Published: December 08, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026